Table 2

Meta-regression analysis: frequency, intervention duration and session duration (adjusted model*)

OutcomeFrequency, sessions per weekDuration of intervention, weeksDuration of session, minutes
nβ95% CIPnβ95% CIPnβ95% CIP
Body mass42−0.0020−0.0390 to 0.04290.924420.0007−0.0097 to 0.01100.89839−0.0016−0.0077 to 0.00450.608
BMI29−0.0068−0.0552 to 0.04170.785290.0008−0.0111 to 0.01260.900280.0018−0.0051 to 0.00860.614
Body fat290.0136−0.0542 to 0.08150.69429−0.0005−0.0119 to 0.01100.93826−0.0024−0.0094 to 0.00460.506
WC180.0041−0.0523 to 0.06040.88718−0.0016−0.0276 to 0.02440.90318−0.0009−0.0127 to 0.01100.886
WHR140.0046−0.1122 to 0.12150.938140.0020−0.0126 to 0.01640.785140.0009−0.0128 to 0.01450.899
SBP350.0418−0.0058 to 0.08850.085350.0073−0.0153 to 0.02880.52734−0.0075−0.0150 to −0.0000.050
DBP33−0.0247−0.0743 to 0.02490.328330.01350.0061 to 0.03300.17732−0.0029−0.0096 to 0.00390.408
TC380.0393−0.0163 to 0.09500.166380.0108−0.0108 to 0.02330.09335−0.0038−0.0114 to 0.00390.338
HDL-C360.0035−0.0492 to 0.05620.895360.0012−0.0103 to 0.01270.83833−0.0004−0.0102 to 0.00930.931
LDL-C350.0367−0.0172 to 0.09050.182350.02020.0081 to 0.03230.00133−0.0055−0.0151 to 0.00400.256
TG33−0.0004−0.0534 to 0.05260.989330.0000−0.0183 to 0.01830.999310.00770.0008 to 0.01460.029
FG17−0.0420−0.1372 to 0.05330.38817−0.0085−0.0476 to 0.03060.67116−0.0062−0.0170 to 0.00460.261
VO2max 31−0.0125−0.0639 to 0.03890.633310.02540.0043 to 0.04650.018290.0071−0.0024 to 0.01650.142
  • *Adjusted for age.

  • β, linear regression coefficient; BMI, body mass index (kg/m2); DBP, diastolic blood pressure (mm Hg); FG, fasting glucose (mmol/L); HDL-C, high-density lipoprotein cholesterol (mmol/L); LDL-C, low-density lipoprotein cholesterol (mmol/L); n, number of comparisons, body mass (kg); SBP, systolic blood pressure (mm Hg); TC, total cholesterol (mmol/L); TG, triglycerides (mmol/L); VO2max, maximal oxygen uptake (mL/(kg·min); WC, waist circumference (cm); WHR, waist-to-hip ratio.